explore -WSS

explore

author：Wikipedia 2025-09-30 09:30:04 - browse：2

Portrait of Don Davis -- health policy coverage from STAT — U.S. Representative Don Davis (D-N.C.) Wikimedia Commons

WASHINGTON — Two Republican lawmakers who introduced legislation to water down the Inflation Reduction Act’s Medicare drug price negotiation program managed to find themselves a Democratic co-sponsor — even though every single Democrat in Congress in 2022 voted for the legislation.

They found their perfect candidate in Rep. Don Davis, a Democrat representing a North Carolina district that includes parts of the state’s Research Triangle. He came to Washington in 2023, so didn’t vote on the original law. He received donations in 2023 from the political action committees for Gilead, Astellas, Genentech, Bayer, Pfizer, Novo Nordisk, GSK, Bristol Myers Squibb, BIO, Amgen, Boehringer Ingelheim, Merck, AbbVie, and Eli Lilly.

“We must support the development of critical, life-sustaining medical treatments and cures,” Davis said in a written statement, and a spokesperson declined to elaborate. He is joined on the bill by Rep. Greg Murphy (R-N.C.) and Brett Guthrie (R-Ky.), the Energy and Commerce health subcommittee chairman.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Chinese researcher claims birth of first gene

WSS

Here’s what’s in the FDA plan to include pregnant women in clinical trials

ACIP vaccine advisory panel sees its vacancies filled

Medicare Advantage insurers pressure Biden for bigger payments

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Diabetes management: Digital health tools fall short, study says

Medical devices makers are asking for forgiveness, not permission

Wikipedia

explore

Wikipedia

ChatGPT in medicine: STAT answers readers' burning questions

Medicare Advantage insurers pressure Biden for bigger payments

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Mirador, a new biotech startup, launches with $400 million

Tori Bowie and the unacceptable rates of Black maternal death

What Kate Middleton's cancer revelation might teach the world

The high cost of giving birth even with insurance

STAT Boddities: What happens to the brain when we get scared?

Medicare details structure of new drug price negotiation program

Cancer, immunology, HIV research ensnared in fetal tissue politics

hotspot

'Patient friction coefficient' can gauge a clinical trial's patient burden

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Why don't Americans have at

Amylyx and the next ALS drug test, plus a chat with CRISPR's CEO

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Here’s what’s in the FDA plan to include pregnant women in clinical trials

hotspot

hotspot

focus

focus